Certified by Founder Lodge 
                                        
                                        CytoTronics
 
                                                 United States  -  Boston, Massachusetts 
                                             START UP 
                                                                                    1 Disclosed Funding Rounds $13,500,000
                                            0 Participating Investments
- 
                                                Founded date 
                                                
2020
 - 
                                                Operating Status 
                                                
Active
 - 
                                                Last Funding Type 
                                                
Seed
 - 
                                                Company Type 
                                                
For Profit
 - Website
 - Contact
 - Social Links
 
                                            CytoTronics is commercializing technology emerging from the Harvard University labs to bring unique insights to drug discovery. A revolutionary approach to studying cell biology, powered by m
                                        
                                        
                                        
                                                                                
                                        
                                                                                | Date | Round | Raised | Participating Investors | 
|---|---|---|---|
| September, 06 ,2024 | Seed | $13,500,000 | 
                                                
 Anzu Partners
                                                                                
 Draper Associates
                                                                                
 BoxOne Ventures
                                                                                
                                                                            
 LYFE Capital
                                                                                
                                                                            
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
                                                                        
                                Helex |  $3,500,000  | (Nov 4, 2025)
                                                                        
                                xMEMS |  $21,000,000  | (Nov 4, 2025)
                                                                        
                                Vesence |  $9,000,000  | (Oct 30, 2025)
                                                                        
                                Homecourt |  $8,000,000  | (Oct 30, 2025)
                                                                        
                                Reflectiz |  $22,000,000  | (Oct 30, 2025)